The largest database of trusted experimental protocols

Immunomagnetic beads

Manufactured by STEMCELL
Sourced in Canada, United States

Immunomagnetic beads are small, uniform, and superparamagnetic particles that can be coated with specific antibodies or ligands. They are used for the separation, isolation, and enrichment of target cells, proteins, or other biomolecules from complex biological samples.

Automatically generated - may contain errors

26 protocols using immunomagnetic beads

1

Cultivation and Activation of Human Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
293T human embryonic kidney cells (obtained from ATCC) and TZM-bl cells (NIH AIDS Reagent Program) were maintained at 37°C under 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) (Wisent, St. Bruno, QC, Canada), supplemented with 5% fetal bovine serum (FBS) (VWR, Radnor, PA, USA) and 100 U/mL penicillin/streptomycin (Wisent). 293T cells were derived from 293 cells, into which the simian virus 40 T-antigen was inserted. TZM-bl cells were derived from HeLa cells and were engineered to stably express high levels of human CD4 and CCR5 and to contain the firefly luciferase reporter gene under the control of the HIV-1 promoter (Platt et al., 1998 (link)). Human peripheral blood mononuclear cells (PBMCs) from ten HIV-negative individuals (8 males and 2 females, unknown age) and five antiretroviral therapy (ART)-treated HIV-positive individuals (all males) obtained by leukapheresis and Ficoll-Paque density gradient isolation were cryopreserved in liquid nitrogen until further use. CD4+ T lymphocytes were purified from resting PBMCs by negative selection using immunomagnetic beads per the manufacturer’s instructions (StemCell Technologies, Vancouver, BC) and were activated with phytohemagglutinin-L (10 μg/mL) for 48 h and then maintained in RPMI 1640 (Thermo Fisher Scientific, Waltham, MA, USA) complete medium supplemented with rIL-2 (100 U/mL).
+ Open protocol
+ Expand
2

Isolation and Culture of Primary Human Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human embryonic kidney cells (obtained from ATCC) were grown as previously described (Richard et al., 2015 (link); Veillette et al., 2014b (link)). HEK293T cells were derived from female human embryonic kidney cells, into which the simian virus 40 T-antigen was inserted. Primary human PBMCs, and CD4+ T cells were isolated, activated and cultured as previously described (Richard et al., 2015 (link); Veillette et al., 2014b (link)). Briefly, PBMCs were obtained by leukapheresis from 7 HIV-uninfected healthy adult (6 males, 1 female) donors. CD4+ T lymphocytes were purified from resting PBMCs by a negative selection using immunomagnetic beads per the manufacturer’s instructions (StemCell Technologies, Vancouver, BC). CD4+ T lymphocytes were activated with phytohemagglutinin-L (10 μg/ mL) for 48 hours and then maintained in RPMI 1640 complete medium supplemented with rIL-2 (100 U/mL). Primary CD4 T cells were isolated from PBMCs obtained from 7 viremic untreated HIV-1-infected individuals (5 males, 2 females). Purified CD4+ T cells were activated with PHA-L at 10 μg /ml for 36 hours and then cultured for 6 days in RPMI-1640 complete medium supplemented with rIL-2 (100U/ml).
+ Open protocol
+ Expand
3

Isolation and Purification of PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were isolated from blood by density gradient centrifugation (Ficoll-Paque; Pharmacia, Uppsala, Sweden) and cryopreserved in 10% dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO) with 90% fetal bovine serum (FBS; Wisent, Inc. St. Bruno, QC, Canada). CD4 T cells were isolated from thawed PBMC by positive selection using immunomagnetic beads (STEMCELL Technologies, Inc. Vancouver, BC, Canada). The purity of the CD4 cell population was verified by flow cytometry (average 95.3%). NK cells were isolated from thawed PBMC by negative selection (STEMCELL Technologies, Inc.) and yielded an average purity of 97.2%.
+ Open protocol
+ Expand
4

Culturing and Activating Primary CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, 293T human embryonic kidney cells (obtained from ATCC, Manassas, VA, USA) were cultured at 37 °C under 5% CO2 in Dulbecco’s modified Eagle’s medium (Wisent) containing 5% fetal bovine serum (VWR, Radnor, PA, USA) and 100 µg/mL of penicillin-streptomycin (Wisent, St. Bruno, QC, Canada). Primary CD4+ T lymphocytes were purified from resting PBMCs by negative selection and activated as previously described [12 (link),13 (link)]. Briefly, PBMC were obtained by leukapheresis. CD4+ T lymphocytes were purified using immunomagnetic beads as per the manufacturer’s instructions (StemCell Technologies, Vancouver, BC, Canada). CD4+ T lymphocytes were activated with phytohemagglutinin-L (PHA-L; 10 µg/mL) for 48 h and then maintained in RPMI 1640 (Gibco, Waltham, MA, USA) complete medium supplemented with rIL-2 (100 U/mL).
+ Open protocol
+ Expand
5

Culturing Human Cell Lines and Primary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human embryonic kidney cells (obtained from the ATCC) were grown as previously described (3 (link), 9 (link)). TZM-bl cells were cultured as we described previously (77 (link)). Primary human PBMCs and CD4+ T cells were isolated, activated, and cultured as previously described (3 (link), 9 (link)). Briefly, PBMCs were obtained by leukapheresis, and CD4+ T lymphocytes were purified from resting PBMCs by negative selection using immunomagnetic beads (StemCell Technologies, Vancouver, BC, Canada) according to the manufacturer's instructions and were activated with phytohemagglutinin-L (10 μg/ml) for 48 h and then maintained in RPMI 1640 complete medium supplemented with recombinant interleukin 2 (rIL-2) (100 U/ml).
+ Open protocol
+ Expand
6

Isolation and culture of HUVECs, CD34+ cells, and primary MKs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were purchased from the cell bank of the Chinese Academy of Sciences (CAS, Shanghai) and cultured in Minimum Essential Medium (Gibco, USA) with 10% fetal bovine serum. CD34+ cells and human primary MKs were obtained from human umbilical cord blood using immunomagnetic beads (Stem Cell Technologies, Canada) as previously described [16 (link)]. The CD34+ cells were then seeded in 24-well plates with a density of 4 × 104/well, and were further cultured in serum-free medium (Stem Cell Technologies, Canada) containing 20 ng/ml recombinant human thrombopoietin (rhTPO) and 1% penicillin/streptomycin. The use of human umbilical cord blood was approved by the Human Medical Ethics Committee of the Third Military Medical University.
+ Open protocol
+ Expand
7

Chimerism Determination Post-Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Post-transplantation D30 (range, 20-50) and 100 (range, 80-120) chimerism was determined using recipient PB or BM samples collected in EDTA. “Total donor cell” chimerism was performed on buffy coat leukocytes. “T-cell” chimerism was on Ficoll Hypaque separated lymphocytes from which purified CD3+ T-cells were isolated using immunomagnetic beads (Stem Cell Technologies Inc.). Pretransplantation PB samples were used to determine the donor and recipient genotypes based on 9 CODIS Short Tandem Repeat loci using the Applied Biosystems Profiler Plus® kit with the ABI 3130 capillary genetic analyzer to determine the alleles at each locus. Informative alleles unique to either donor or recipient were used to calculate % donor chimerism at each locus using the median peak intensity of amplicons attributable to donor divided by the sum of all amplicons at that locus. In cases where there were only unique recipient amplicons, % donor chimerism was calculated as (100 – % recipient chimerism). 95% confidence interval for chimerism was ±5%.
+ Open protocol
+ Expand
8

Isolation and Activation of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human embryonic kidney cells and P815 mouse lymphoblast-like mastocytoma cells (obtained from ATCC) were grown as previously described (39 (link), 65 (link)). Primary human peripheral blood mononuclear cells (PBMCs), CD4+ T cells, and NK cells were isolated, activated, and cultured as previously described (66 (link), 67 (link)). Briefly, PBMCs were obtained by Ficoll density gradient from whole-blood samples obtained from 9 different HIV-1-negative donors. CD4+ T lymphocytes and NK cells were purified from resting PBMCs by negative selection using immunomagnetic beads per the manufacturer’s instructions (StemCell Technologies, Vancouver, BC, Canada). CD4+ T cells were activated with phytohemagglutinin-L (10 μg/ml) for 48 h and then maintained in RPMI 1640 complete medium supplemented with recombinant interleukin-2 (100 U/ml; R&D Systems) (see Fig. S1 in the supplemental material). NK cells were isolated and rested overnight in RPMI 1640 complete medium on the day prior to the redirection and killing assays.
+ Open protocol
+ Expand
9

Culturing HEK293T, TZM-bl, and Primary Human T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T human embryonic kidney cells and TZM-bl cells obtained from ATCC were grown as previously described [7 (link),17 (link)]. Primary human PBMCs and CD4+ T cells were isolated, activated, and cultured as previously described [7 (link),17 (link)]. Briefly, PBMC were obtained by leukapheresis. CD4+ T lymphocytes were then purified from resting PBMCs via negative selection using immunomagnetic beads per the manufacturer’s instructions (StemCell Technologies, Vancouver, BC, Canada). CD4+ T lymphocytes were activated with phytohemagglutinin-L (10 µg/mL) for 48 h and then maintained in RPMI 1640 complete medium supplemented with rIL-2 (100 U/mL).
+ Open protocol
+ Expand
10

Cytotoxicity Assay for CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CytoTox 96 non-radioactive cytotoxicity assay kit (Promega, Madison, WI) was used to measure the cytotoxic activity of CD8+ T cells against tumor cells. After 1 week of tumor inoculation, splenocytes were harvested from tumor-bearing mice and stimulated with hepa1-6 cell lysates plus rhIL-2 (100 U/mL) for 4 days. For assays of examining the in vitro function of IL-1α, splenocytes were harvested from mice and stimulated with hepa1-6 cell lysates plus rhIL-2 (100 U/mL) with or without 25 ng/ml recombinant IL-1α proteins (R&D Systems, Minneapolis, MN) for 4 days. CD8+ T cells were sorted from splenocytes by negative selection using immunomagnetic beads (StemCell Technologies, Vancouver, BC) according to the manufacturer’s protocol. Then the cytotoxicity assay was performed using hepa1-6 cells as the target cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!